VYM vs XBI
Vanguard High Dividend Yield ETF vs SPDR S&P Biotech ETF
- • VYM has the lower expense ratio at 0.04% vs 0.35% for XBI.
- • VYM pays a higher dividend yield (2.30%).
Side-by-side metrics
| Metric | VYM | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.30% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $96.17B | $10.73B |
YTD return | 12.69% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 1.10 |
P/E ratio | 21.21 | — |
Last price | $161.05 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VYM top holdings
| AVGO | Broadcom Inc | 8.49% |
| JPM | JPMorgan Chase & Co | 3.13% |
| XOM | Exxon Mobil Corp | 2.52% |
| JNJ | Johnson & Johnson | 2.23% |
| CSCO | Cisco Systems Inc | 1.97% |
| CAT | Caterpillar Inc | 1.67% |
| ABBV | AbbVie Inc | 1.59% |
| ORCL | Oracle Corp | 1.56% |
| UNH | UnitedHealth Group Inc | 1.42% |
| CVX | Chevron Corp | 1.41% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VYM
VYM (Vanguard High Dividend Yield ETF) is US large-caps with above-average dividend yields. Managed by Vanguard, the fund carries $96.2B in assets under management, an expense ratio of 0.04%, a dividend yield of 2.30%. Its largest holding is Broadcom Inc (AVGO), which represents 8.5% of the portfolio. Real Estate is the fund's largest sector exposure at 0.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.